Lipid panel claims look straightforward, yet small coding mistakes can trigger denials or lost reimbursement. Billers may unbundle the panel, report direct LDL without an actual assay, or use a diagnosis that does not support the test. These errors slow payment and increase compliance risk. This 2026 guide explains CPT code 80061, its components, billing rules, Medicare coverage, documentation, modifier QW, reimbursement and common denial solutions.
What Is CPT Code 80061?
CPT code 80061 identifies a lipid panel that measures total cholesterol, high-density lipoprotein cholesterol and triglycerides. Healthcare providers order this laboratory panel to screen for cardiovascular risk, evaluate abnormal lipid levels and monitor patients receiving treatment for lipid disorders.
CPT 80061 identifies the laboratory service. It does not describe the patient’s diagnosis or guarantee insurance coverage. Billers must report an appropriate ICD-10-CM diagnosis that reflects the documented reason for the test.
CPT 80061 Description at a Glance
| Item | CPT 80061 information |
|---|---|
| Code | 80061 |
| Code system | CPT Category I |
| Service | Lipid panel |
| Required components | Total cholesterol, direct HDL cholesterol and triglycerides |
| Common use | Screening, diagnosis and treatment monitoring |
| Typical units | One unit for one completed panel |
| Direct LDL code | CPT 83721 |
| Medicare payment system | Clinical Laboratory Fee Schedule |
| Modifier | QW when the specific waived test system requires it |
CPT 80061 is a CPT code, not an ICD-10-CM diagnosis code or a HCPCS Level II code.
What Tests Are Included in CPT 80061?
A complete CPT 80061 lipid panel contains three required laboratory tests:
| Laboratory test | Individual CPT code | Relationship to 80061 |
| Total cholesterol | 82465 | Required component |
| Direct HDL cholesterol | 83718 | Required component |
| Triglycerides | 84478 | Required component |
When a laboratory performs all three components, it should report CPT 80061. The laboratory should not report 82465, 83718 and 84478 separately for the same completed panel.
If the laboratory performs only one or two components, it should report the applicable individual codes. Reporting 80061 without completing all required tests may create an inaccurate claim.
Does CPT 80061 Include LDL Cholesterol?
A lipid report commonly includes an LDL cholesterol result. However, the laboratory often calculates that result from other measurements rather than performing a separate direct LDL assay.
A calculated LDL result does not support CPT 83721. The laboratory should report CPT 83721 only when it performs a direct LDL measurement and the documentation, medical necessity and payer rules support that service.
This distinction creates one of the most common lipid panel billing errors. A report may display four lipid values, but CPT 80061 contains three required performed components.
What Is CPT Code 80061 Used For?
Healthcare providers may order a lipid panel for several reasons, including:
- Cardiovascular disease screening
- Evaluation of elevated cholesterol or triglycerides
- Diagnosis and monitoring of lipid disorders
- Monitoring dietary or medication therapy
- Cardiovascular risk assessment for patients with diabetes
- Evaluation of certain renal, thyroid, hepatic or metabolic conditions
- Follow-up after an abnormal screening result
The medical record should clearly identify whether the provider ordered preventive screening or diagnostic testing. That distinction affects diagnosis selection, Medicare frequency rules and patient responsibility.
CPT Code 80061 Billing Guidelines
Accurate billing starts with the laboratory order and the tests actually performed. The laboratory should confirm that the order supports a complete lipid panel and that it performed all three required components.
Billers should follow these steps before submitting the claim:
- Confirm the ordering provider’s request.
- Verify that the laboratory performed all three panel components.
- Determine whether the provider ordered screening or diagnostic testing.
- Select the diagnosis from the medical record.
- Review frequency and payer coverage requirements.
- Confirm the laboratory’s CLIA status.
- Append modifier QW only when applicable.
- Submit CPT 80061 with the appropriate units.
A laboratory normally reports one unit for one completed lipid panel. It should not submit multiple units routinely without distinct testing, a valid clinical reason and complete documentation.
Avoid Unbundling the Lipid Panel
Unbundling occurs when a laboratory separately reports component codes even though one panel code describes the completed service. If the laboratory performs total cholesterol, HDL cholesterol and triglycerides as one panel, it should submit CPT 80061 instead of the three individual codes.
Incorrect unbundling may trigger claim edits, denials or payer review. Therefore, the billing team should compare the completed tests with the applicable panel code before claim submission.
CPT 80061 vs. CPT 83721
CPT 80061 and CPT 83721 describe different laboratory services.
| Billing situation | Correct coding approach |
| Laboratory calculates LDL from panel results | Report CPT 80061 only |
| Laboratory performs a direct LDL assay | Evaluate CPT 83721 |
| Laboratory performs all three panel components | Report CPT 80061 |
| Laboratory performs only one or two components | Report the individual component codes |
| Laboratory performs 80061 and direct LDL on the same date | Check medical necessity, NCCI edits and payer policy |
A provider may order direct LDL testing when calculated LDL cannot provide a reliable result or when the patient’s clinical circumstances support direct measurement. However, the laboratory should not assume that every direct LDL test qualifies for separate reimbursement.
Before reporting 80061 and 83721 together, confirm that the laboratory performed a separate direct assay. Then review current NCCI edits, payer policy and modifier requirements. Never use a modifier only to bypass a claim edit.
Diagnoses and Medical Necessity for CPT 80061
The diagnosis should explain why the provider ordered the lipid panel. Common diagnosis categories may include hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, diabetes and cardiovascular disease.
Potential ICD-10-CM codes may include:
- Z13.220 for an applicable lipid-disorder screening encounter
- E78.5 for unspecified hyperlipidemia
- E78.00 for pure hypercholesterolemia
- E78.1 for pure hyperglyceridemia
- E78.2 for mixed hyperlipidemia
These examples do not guarantee coverage. Billers must select the most specific code supported by the medical record and verify the current payer policy.
The CMS National Coverage Determination for lipid testing identifies diagnostic indications that may support testing. These include atherosclerotic cardiovascular disease, primary and secondary dyslipidemia, diabetes, chronic renal failure, thyroid disorders, pancreatitis and certain hepatic conditions.
Do not replace a diagnostic code with a screening code simply to obtain payment. The diagnosis on the claim must match the provider’s documentation and the actual reason for testing.
Does Medicare Cover CPT Code 80061?
Medicare may cover CPT 80061 as preventive cardiovascular screening or medically necessary diagnostic testing. However, each category follows different coverage and frequency rules.
Preventive Cardiovascular Screening
Medicare Part B covers eligible cardiovascular screening blood tests once every five years. The benefit includes testing for cholesterol, lipid and triglyceride levels.
According to Medicare’s cardiovascular disease screening guidance, the patient pays nothing when the provider accepts assignment and the service meets coverage requirements. The five-year frequency applies to the preventive screening benefit, not every diagnostic lipid panel.
Diagnostic Lipid Testing
Diagnostic testing follows medical-necessity rules. For example, a provider may order a lipid panel to evaluate an abnormal result or monitor treatment for a diagnosed lipid disorder.
CMS states that an annual lipid panel often provides adequate monitoring during stable, long-term therapy. However, CMS may allow individual components or measured LDL more frequently during the first year of treatment, after significant elevations or following treatment changes when documentation supports the need.
Advance Beneficiary Notice
A provider may consider an Advance Beneficiary Notice when it expects Medicare to deny the test because the patient exceeded a frequency limit or the documentation may not support medical necessity.
The provider should issue the notice before performing the service and follow current Medicare requirements. An ABN informs the patient about potential responsibility; it does not make an otherwise noncovered service payable.
Does CPT 80061 Require Modifier QW?
CPT 80061 does not automatically require modifier QW. The laboratory should append QW only when it uses a specific FDA-approved CLIA-waived test system that qualifies for the modifier.
Before adding QW, verify:
- The exact analyzer and test system
- The system’s current waived status
- The laboratory’s CLIA certificate
- The payer’s claim requirements
- The date of service
An office location alone does not justify modifier QW. A physician-office laboratory must use a qualifying waived system and maintain the appropriate CLIA certification.
An incorrect or missing QW modifier can cause a denial. Therefore, billing teams should compare the test system with the current CMS waived-test information instead of applying the modifier automatically.
Can CPT 80061 Be Reported With an Office Visit?
A provider may report an office E/M service and a lipid panel on the same date when the provider performs and documents a medically necessary visit in addition to the laboratory test. Ordering a lipid panel alone does not automatically support an E/M code.
For a low-complexity established-patient encounter, review the CureMD Billers 99213 CPT code guide. If the visit involves moderate medical decision-making or qualifying time, compare the documentation with the 99214 CPT code requirements.
The physician or qualified healthcare professional must document the E/M service independently. The claim should also follow payer rules for same-day laboratory and office services.
CPT Code 80061 Reimbursement in 2026
Medicare generally pays CPT 80061 through the Clinical Laboratory Fee Schedule rather than the Medicare Physician Fee Schedule. Medicare bases most clinical diagnostic laboratory payments on the applicable national payment limitation.
CMS publishes quarterly updates to the 2026 Clinical Laboratory Fee Schedule files. Billing teams should use the latest file for the date of service instead of relying on an undated reimbursement figure.
A fee schedule amount does not guarantee payment. Medicare still requires coverage, medical necessity, correct coding and complete documentation.
Commercial reimbursement varies according to the payer contract, network participation, laboratory arrangement and place of service. Hospital outpatient laboratories may also need to review applicable packaging and facility-payment rules.
CPT 80061 Documentation Requirements
The medical record should support the ordered service and the diagnosis submitted on the claim. Strong documentation should include:
- A valid laboratory order
- The reason for testing
- Screening or diagnostic intent
- The conditions under evaluation or management
- The three panel components performed
- Specimen and date-of-service information
- Laboratory and CLIA details
- The test system when the claim includes QW
- The direct measurement method when reporting 83721
- Relevant previous tests and treatment changes
- ABN information when applicable
The record should allow a reviewer to understand what the laboratory performed and why the patient needed the test.
Common CPT 80061 Denials and Corrections
| Denial problem | Possible cause | Recommended correction |
| Medical-necessity denial | Diagnosis does not support the test | Review the order and documented condition |
| Frequency denial | Patient exceeded the applicable limit | Check prior testing and screening or diagnostic status |
| Bundling denial | Laboratory reported components with 80061 | Remove incorrectly unbundled component codes |
| Direct LDL denial | Laboratory calculated LDL instead of measuring it | Confirm whether an actual direct assay occurred |
| QW denial | Modifier or analyzer does not qualify | Verify the test system and CLIA status |
| Duplicate denial | Office and reference laboratory both submitted claims | Identify the performing and billing laboratory |
| Documentation denial | Missing order or clinical reason | Obtain the required supporting documentation |
When correcting a claim, use the information already supported by the medical record. Do not add or change a diagnosis simply to make the claim payable.
Final Takeaway
CPT code 80061 represents a complete lipid panel containing total cholesterol, direct HDL cholesterol and triglycerides. Accurate billing requires all three components, a documented reason for testing and compliance with payer, frequency and CLIA requirements.
Billing teams should distinguish calculated LDL from direct LDL testing, avoid unbundling and verify current reimbursement rules. These steps can reduce preventable denials and support cleaner laboratory claims.
Last reviewed: August 26, 2026
Frequently Asked Questions
What does CPT code 80061 mean?
CPT 80061 identifies a lipid panel that includes total cholesterol, direct HDL cholesterol and triglycerides. Providers use the panel for cardiovascular screening, diagnostic evaluation and treatment monitoring.
What three tests make up CPT 80061?
The three required components are total cholesterol, HDL cholesterol and triglycerides. When the laboratory performs all three, it should report the panel code instead of separate component codes.
Does CPT 80061 include LDL?
The report may include a calculated LDL value, but direct LDL measurement does not form one of the three required panel components. CPT 83721 identifies a separately performed direct LDL assay.
Can CPT 80061 and 83721 appear on the same claim?
They may appear together when the laboratory performs a medically necessary direct LDL assay and current NCCI and payer rules allow separate reporting. Documentation must support both services.
What diagnosis supports CPT 80061?
The correct diagnosis depends on why the provider ordered the test. Examples may include lipid screening, hyperlipidemia, diabetes or cardiovascular disease, but payer requirements can differ.
Does Medicare cover CPT code 80061?
Medicare may cover 80061 for eligible cardiovascular screening once every five years or for medically necessary diagnostic testing. Diagnostic frequency depends on the patient’s condition and treatment.
Does CPT 80061 require modifier QW?
Modifier QW applies only when the laboratory uses an eligible CLIA-waived test system and meets payer requirements. It does not apply automatically to every 80061 claim.
Can a laboratory bill two units of CPT 80061?
A laboratory normally bills one unit for one completed panel. Multiple units require distinct testing, medical necessity and documentation, and they may trigger payer edits.
